MedPath

Assessment of Sleep and Sleep Disruptors in Adolescents With Type 1 Diabetes

Completed
Conditions
Insufficient Sleep
Type 1 Diabetes
Registration Number
NCT05370339
Lead Sponsor
University of Colorado, Denver
Brief Summary

The goal of this study is to identify causes of insufficient sleep and sleep disruptors in adolescents with type 1 diabetes. For this study, adolescents will wear an actigraphy watch and complete sleep diaries for seven days. On completion of the seven days, they will complete several questionnaires regarding sleep, fear of hypoglycemia, and anxiety and depression. A subset of participants will additionally complete a qualitative interview session to obtain a deeper understanding of sleep disruptors and barriers and facilitators to improving sleep health.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Diagnosed with T1D at least 3 months
  • Receive clinical care at the Barbara Davis Center
Read More
Exclusion Criteria
  • Have an active underlying sleep disorder, such as narcolepsy, insomnia, or untreated sleep apnea
  • Participation in an interventional research protocol
  • Unable to complete study procedures
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of nocturnal awakenings per weekOne week per participant

We will identify the number of nocturnal awakenings per week for comparison of those with insufficient sleep identified by actigraphy watch to those with sufficient sleep.

Assessment of facilitators and barriers to good sleep quality and durationOne week per participant

Qualitative interviews will be conducted and analyzed for themes to identify causes of sleep disruptions and any potential barriers or facilitators to improving sleep health.

Secondary Outcome Measures
NameTimeMethod
Identification of common causes of sleep disruptors in adolescents with type 1 diabetesOne week per participant

Sleep diaries will be used to determine common causes of sleep disruptors in adolescents with type 1 diabetes.

Trial Locations

Locations (1)

University of Colorado, Barbara Davis Center

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath